908 Devices Inc., a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced the pricing of its upsized initial public offering of shares of its common stock, with 6,500,000 shares being offered by the Company at a public offering price of $20.00 per share. In addition, the underwriters [...]

PORT WASHINGTON, N.Y.– Pall Corporation, a global leader in filtration, separation and purification, announced a strategic partnership with Single Use Support GmbH, a leading provider of an innovative, end-to-end solution for safe handling of biologics from bulk manufacturing to fill finish. Pall will provide a significant investment and partner with Single Use Support to distribute [...]

Innovative end-to-end scientific research to be managed in CDD Vault Burlingame, California —Collaborative Drug Discovery (CDD) has today announced that its CDD Vault platform will be implemented by Curve Therapeutics Ltd. (Southampton, UK) to manage its genetically-encoded Microcycle platform and the functional hits and leads generated from it. Curve is an innovative drug discovery company [...]

New Carlsbad, California cGMP site will accelerate commercialization of plasmid-based medicines and vaccines WALTHAM, Mass. -- Thermo Fisher Scientific, the world leader in serving science, today announced the construction of a new cGMP plasmid DNA manufacturing facility in Carlsbad, Calif. The site will expand the company's clinical and commercial capabilities for cGMP plasmid DNA used as a critical [...]

The world’s smallest methanizer now available for Shimadzu 2030 GCs Eden Prairie, MN – Activated Research Company (ARC) is excited to announce that the Jetanizer is now available through Shimadzu Scientific Instruments (SSI) for Shimadzu 2030 GC instruments. SSI will be offering the Jetanizer through its headquarters in Columbia, MD directly to end users in the [...]

BOSTON -- NanoMosaic has developed a streamlined platform with novel physical structures, MosaicNeedles™, to enable enhanced-generation digital protein interrogation. The Tessie™ platform eliminates the bottleneck of beads, used for protein capture and labeling, and the limitations associated with them. The novel MosaicNeedle™ structures enable the unlabeled digital quantitation of proteins and nucleic acids across seven [...]

Cambridge Isotope Laboratories, Inc. (CIL), the world leader in stable isotope chemistry and the separation of carbon-13 (13C), recently began a significant capacity optimization of one of the production cascades at the 13C separation facility in Xenia, Ohio. This optimization, which began this past summer and is scheduled for completion in the summer of 2021, will increase the cascade’s 13C production by [...]

Emedgene's artificial intelligence capabilities enhance Illumina's TruSight™ Software Suite providing a scalable and streamlined solution for rare disease interpretation PALO ALTO, California -- Emedgene, a leading precision medicine intelligence company, announces a non-exclusive partnership with Illumina Inc. and the integration of automated interpretation into Illumina's TruSight™ Software Suite for rare genetic diseases. Emedgene's Clinical Rare [...]

BOSTON -- NanoView Biosciences, Inc., and Quantum Design China, a subsidiary of Quantum Design International, today announced an exclusive distribution agreement for NanoView's ExoView® platform in China. "We are pleased to offer customers in China access to the ExoView platform, which allows scientists the unprecedented ability to accurately identify and characterize extracellular vesicles, including exosomes and viruses" said Lamber Cao, General [...]

Sartorius recently recognized startup company MyoGene Bio at the QB3 Pitch Summit, a competition showcasing promising new life science companies. This award provides the company with a $25,000 voucher that they can use for the purchase of any Sartorius products and services to support their development of a gene therapy for Duchenne muscular dystrophy (DMD). [...]